Tremblay M, Fitz-Gibbon L, Wainberg M A
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.
Leukemia. 1988 Dec;2(12 Suppl):233S-240S.
Over a period of six months, we have followed a total of six different EBV-transformed B cell lines, each of which has been infected by the human immunodeficiency virus (HIV-1). The results indicate that all of these lines were initially able to produce progeny HIV-1, but that over time three of them ceased to produce infectious virus and two lines failed to elaborate significant levels of reverse transcriptase activity into the medium. We further found that two of the latter cell lines continued to express the viral antigens p17, p24 and/or gp41, as determined by indirect immunofluorescence assay, at times after progeny HIV-1 could no longer be detected. Those cell lines which continued to secrete progeny HIV-1 did so intermittently with large amounts of virus production on some days but not others. We further found that treatment of such cells with 3' azido-3'-deoxythymidine (AZT) completely inhibited production of progeny HIV-1.
在六个月的时间里,我们总共追踪了六种不同的EB病毒转化的B细胞系,每一种都感染了人类免疫缺陷病毒(HIV-1)。结果表明,所有这些细胞系最初都能够产生HIV-1子代病毒,但随着时间的推移,其中三个细胞系停止产生有传染性的病毒,两个细胞系未能向培养基中释放出显著水平的逆转录酶活性。我们进一步发现,通过间接免疫荧光测定法确定,在无法再检测到HIV-1子代病毒后的某些时候,后两个细胞系仍继续表达病毒抗原p17、p24和/或gp41。那些继续分泌HIV-1子代病毒的细胞系间歇性地产生病毒,有些日子产生大量病毒,而有些日子则不产生。我们还发现,用3'叠氮-3'-脱氧胸苷(AZT)处理这些细胞可完全抑制HIV-1子代病毒的产生。